| Pathologic grading of malignant pleural mesothelioma: an evidence-based proposal G Pelosi, M Papotti, L Righi, G Rossi, S Ferrero, S Bosari, F Calabrese, ... Journal of Thoracic Oncology 13 (11), 1750-1761, 2018 | 32 | 2018 |
| Prognostic value of the hemoglobin/red cell distribution width ratio in resected lung adenocarcinoma F Petrella, M Casiraghi, D Radice, A Cara, G Maffeis, E Prisciandaro, ... Cancers 13 (4), 710, 2021 | 23 | 2021 |
| Non-intubated thoracoscopic lobectomies for lung cancer: an exploratory systematic review and meta-analysis E Prisciandaro, L Bertolaccini, G Sedda, L Spaggiari Interactive CardioVascular and Thoracic Surgery 31 (4), 499-506, 2020 | 15 | 2020 |
| Minimally invasive anatomical segmentectomy versus lobectomy in stage IA non-small cell lung cancer: a systematic review and meta-analysis L Bertolaccini, E Prisciandaro, C Bardoni, A Cara, C Diotti, L Girelli, ... Cancers 14 (24), 6157, 2022 | 14 | 2022 |
| Artificial neural networks in lung cancer research: A narrative review E Prisciandaro, G Sedda, A Cara, C Diotti, L Spaggiari, L Bertolaccini Journal of Clinical Medicine 12 (3), 880, 2023 | 10 | 2023 |
| A focused review on primary graft dysfunction after clinical lung transplantation: a multilevel syndrome J Van Slambrouck, D Van Raemdonck, R Vos, C Vanluyten, A Vanstapel, ... Cells 11 (4), 745, 2022 | 10 | 2022 |
| Impact of the extent of lung resection on postoperative outcomes of pulmonary metastasectomy for colorectal cancer metastases: an exploratory systematic review E Prisciandaro, LJ Ceulemans, DE Van Raemdonck, H Decaluwe, ... Journal of Thoracic Disease 14 (7), 2677, 2022 | 9 | 2022 |
| Safety and feasibility of thoracic malignancy surgery during the COVID-19 pandemic J Seitlinger, C Wollbrett, A Mazzella, S Schmid, F Guerrera, DB Nkomo, ... The Annals of Thoracic Surgery 112 (6), 1870-1876, 2021 | 9 | 2021 |
| Urinary biomarkers for early diagnosis of lung cancer R Gasparri, G Sedda, V Caminiti, P Maisonneuve, E Prisciandaro, ... Journal of Clinical Medicine 10 (8), 1723, 2021 | 9 | 2021 |
| Chest wall resection and reconstruction for primary and metastatic sarcomas: an 11-year retrospective cohort study E Prisciandaro, R Hustache-Castaing, A Michot, J Jougon, M Thumerel Interactive CardioVascular and Thoracic Surgery 32 (5), 744-752, 2021 | 8 | 2021 |
| Incidental diagnosis of pulmonary mycobacteriosis among patients scheduled for lung cancer surgery: results from a series of 3224 consecutive operations F Petrella, M Casiraghi, E Prisciandaro, L Gherzi, L Spaggiari Heliyon 5 (3), 2019 | 7 | 2019 |
| Pneumonectomy and broncho-pleural fistula: Predicting factors and stratification of the risk A Mazzella, L Bertolaccini, G Sedda, E Prisciandaro, M Loi, GL Iacono, ... Updates in Surgery 74 (4), 1471-1478, 2022 | 6 | 2022 |
| Lung cancer stage distribution from before COVID-19 through 18 months of the pandemic: the experience of a large-volume oncological referral centre L Bertolaccini, O Ciani, E Prisciandaro, G Sedda, L Spaggiari European Journal of Surgical Oncology 48 (2), 470-471, 2022 | 6 | 2022 |
| A proposal for a postoperative protocol for the early diagnosis of bronchopleural fistula after lung resection surgery L Bertolaccini, E Prisciandaro, J Guarize, L Spaggiari Journal of Thoracic Disease 13 (11), 6495, 2021 | 6 | 2021 |
| Prognostic value of red blood cell distribution width in resected pN1 lung adenocarcinoma F Petrella, M Casiraghi, D Radice, E Prisciandaro, S Rizzo, L Spaggiari Cancers 12 (12), 3677, 2020 | 6 | 2020 |
| Outcomes and Safety Analysis in Superior Vena Cava Resection for Extended Thymic Epithelial Tumors Outcomes and Safety Analysis in Superior Vena Cava Resection for Extended … L Bertolaccini, E Prisciandaro, D Galetta, M Casiraghi, J Guarize, ... The Annals of Thoracic Surgery, 2020 | 6* | 2020 |
| One-shot diagnosis: EBUS-TBNA as a single procedure for thyroid, pulmonary and lymph nodal lesions N Filippi, E Prisciandaro, J Guarize, SM Donghi, G Sedda, L Spaggiari Advances in Respiratory Medicine 87 (3), 194-195, 2019 | 5 | 2019 |
| Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer L Bertolaccini, E Prisciandaro, J Guarize, L Girelli, G Sedda, N Filippi, ... Frontiers in Oncology 12, 933278, 2022 | 4 | 2022 |
| When less is more: EBUS-TBNA for the diagnosis of pleural lesions SM Donghi, E Prisciandaro, G Sedda, J Guarize, L Spaggiari Innovations 14 (5), 473-475, 2019 | 4 | 2019 |
| OA06. 05 consensual definition of stage III NSCLC resectability: EORTC-Lung Cancer Group Initiative with other scientific societies AM Dingemans, J Remon, L Hendriks, J Edwards, C Faivre-Finn, ... Journal of Thoracic Oncology 18 (11), S57-S58, 2023 | 3 | 2023 |
